Saturday 17 October 2026
Export ETAOF’s income statement to Excel — free account
ETAO International Co., Ltd.
ETAOF Healthcare Health Information Services
ETAO International Co., Ltd.’s revenue for fiscal 2022 (year ended December 2022) was $58.1 million. Operating cash flow growth for five consecutive years.
0.00
0.00
NaN
Follow ETAOF
| Dec '22 | Dec '21 | Jan '21 | Dec '17 | |
|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — |
Altman Z-Score |
(58.66) | 8.82 | — | — |
P/S ratio |
0.00 | 0.00 | — | — |
Altman Z″-Score (non-manufacturers) |
(150.41) | 1.71 | — | — |
P/FCF ratio |
93.59 | 0.00 | — | — |
Beneish M-Score |
(89.57) | — | — | — |
P/Operating CF |
89.46 | (46,415.85) | — | — |
P/B ratio |
0.00 | 26.68 | — | — |
Price to Tangible BV |
0.00 | 26.68 | — | — |
EV/Sales |
0.00 | 0.00 | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — |
EV/Operating CF |
92.38 | 0.00 | — | — |
EV/FCF |
92.38 | 0.00 | — | — |
Quick Ratio |
0.65 | 0.51 | 0.17 | — |
Current Ratio |
0.77 | 0.69 | 0.18 | — |
Net Debt/EBITDA |
0.02 | 2.85 | 1.02 | — |
Debt/Assets |
2.01% | 0.17% | 0.00% | 0.00% |
Debt/Equity |
(0.18) | 0.00 | 0.00 | — |
Asset Turnover |
0.42 | 0.39 | 0.00 | — |
Operating CF/Net income |
(0.01) | 0.02 | 0.76 | — |
Capex/Depreciation |
(0.32) | (1.39) | — | — |
Interest Coverage |
(1,463.46) | (10.23) | (304.09) | — |
| (1,209.41%) | (10.20%) | (0.63%) | — | |
| (651.90%) | (7.62%) | (1.22%) | — | |
ROIC |
0.00% | (2.36%) | 0.00% | — |
Return on Tangible Assets |
(9,261.09%) | (143.62%) | 20.30% | — |
Average Days of Receivables |
50.90 | 59.65 | — | — |
Research and Development Expense of Revenue |
3.67% | 1.72% | — | — |
Selling, General and Administrative Expense of Revenue |
1,298.69% | 38.94% | — | — |
Intangible Assets out of Total Assets |
0.02 | 0.73 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
1,267.65% | 9.37% | — | — |
Graham Net Nets |
(0.03) | 0.00 | — | — |
Graham Number |
69.48 | 0.00 | — | — |
Earnings Yield |
(88.55%) | (1.40%) | — | — |
Free Cash Flow Yield |
1.07% | 0.00% | — | — |
Revenue per Share |
11.61 | 10.67 | 0.00 | — |
Operating CF per Share |
2.16 | (0.05) | (0.04) | — |
Capex per Share |
(0.13) | (0.47) | 0.00 | — |
Free Cash Flow per Share |
2.04 | (0.52) | (0.04) | — |
Cash per Share |
2.83 | 2.20 | 0.05 | — |
Shareholders Equity per Share |
(1.20) | 30.85 | 7.45 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | — |
Book value per Share |
(1.20) | 30.85 | 7.45 | — |
Free Cash Flow |
10.19 | (2.61) | (0.25) | — |
Working Capital |
(8.01) | (11.99) | (1.64) | — |
Capital Expenditures |
(0.63) | (2.36) | — | — |
Net Current Asset Value |
(32.53) | (41.31) | (1.64) | — |
EV/EBIT |
0.00 | 0.00 | — | — |
Capex to Sales |
0.01 | 0.04 | — | — |
Price to Operating Income |
0.00 | 0.00 | — | — |
| Other line items | ||||
Depreciation/Fixed assets |
0.11 | 0.09 | — | — |
Cash ROIC |
110.21% | (1.57%) | (0.48%) | — |
Accounts Receivable Turnover |
6.91 | 0.00 | — | — |
Accounts Payable Turnover |
5.23 | 0.00 | — | — |
Inventory Turnover |
19.20 | 0.00 | — | — |
Average Days of Payables |
70.68 | 72.53 | — | — |
Days of Inventory on Hand |
18.59 | 20.48 | — | — |
Average Receivables |
8.41 | — | — | — |
Average Payables |
7.47 | — | — | — |
Average Inventory |
2.03 | — | — | — |
Average Assets |
137.55 | 138.33 | 27.27 | — |
Average Common Equity |
74.14 | 103.40 | 52.54 | — |
Columns are period end dates · fundamentals updated 5 Oct 2026